Akso Health Group (AHG)
NASDAQ: AHG · Real-Time Price · USD
0.8480
-0.0258 (-2.95%)
At close: Sep 4, 2026, 4:00 PM EDT
0.9120
+0.0640 (7.55%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Akso Health Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
7261,953425170839
Market Cap Growth
-22.56%359.39%150.55%1990.59%-78.99%28.42%
Enterprise Value
7291,944341171835
Last Close Price
0.852.281.181.160.351.69

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-5.085.085.085.085.08
PS Ratio
52.52141.2228.7770.290.626.44
PB Ratio
4.0210.802.131.230.923.15
P/TBV Ratio
4.0210.802.361.230.933.15
P/FCF Ratio
--415.76125.59--
P/OCF Ratio
--361.20125.59--
PEG Ratio
-0.510.510.510.510.51

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
52.68140.5623.0570.650.595.86
EV/FCF Ratio
--333.10126.24--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.010.010.010.011.103.03
Debt / FCF Ratio
--2.041.48--
Net Debt / Equity Ratio
0.010.01-0.87-0.600.201.53
Net Debt / EBITDA Ratio
-1.35-1.3598.21--0.12-7.70
Net Debt / FCF Ratio
-0.17-0.17-170.28-61.55-0.54-2.17
Asset Turnover
0.070.070.080.030.320.13
Inventory Turnover
70.9270.9278.962.442.51-
Quick Ratio
0.170.1712.8323.701.340.37
Current Ratio
21.7721.7714.2039.521.761.24
Return on Equity (ROE)
-9.85%-9.85%-80.26%-12.38%-123.87%-27.75%
Return on Assets (ROA)
-1.24%-1.24%-1.37%-6.64%-21.42%-3.25%
Return on Invested Capital (ROIC)
-2.18%-3.84%-9.78%-26.24%-68.50%-10.64%
Return on Capital Employed (ROCE)
-2.20%-2.20%-2.00%-6.20%-161.40%-20.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-2.57%-0.96%-31.75%-5.57%-16.75%-43.61%
FCF Yield
-1.76%-0.66%0.24%0.80%-40.08%-22.33%
Buyback Yield / Dilution
-153.50%-153.50%-504.37%-106.30%-15.07%-22.06%
Total Shareholder Return
-153.50%-153.50%-504.37%-106.30%-15.07%-22.06%
SEC Filings: 10-K · 10-Q